CREB3L3 and hyperlipidemia: The liver-specific knockout of Creb3l3 in mice exhibits hyperlipidemia and nonalcoholic steatohepatitis, while the intestine-specific Creb3l3 knockout mice were not hyperlipidemic but did show a modest increase in the amount of total body fat (14).